Noticias

NOVEDADES GOLD 2024 - 21 de Noviembre de 2023

NOVEDADES GOLD 2024 – 21 Noviembre 2023. 17-19h

octubre 2, 2023

NOVEDADES GOLD 2024, Reunión mixta el próximo 21 Noviembre 2023, de 17 a 19h. Regístrate cuanto antes (gratuito) en la modalidad Online o Presencial.

The song of the cell: una exploración de la medicina y del nuevo humano

septiembre 25, 2023

Del autor de El emperador de todas las enfermedades, ganador del Premio Pulitzer, y El gen, bestseller número uno del New York Times, llega su libro más espectacular hasta el momento, una exploración de la medicina y nuestra nueva y radical capacidad para manipular las células.

Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice

septiembre 23, 2023

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as «Aging (Albany NY)» and «Aging-US» by Web of Science) Volume 15, Issue 14, entitled, «Human senescent fibroblasts trigger progressive lung fibrosis in mice.»

COPD and multimorbidity: recognising and addressing a syndemic occurrence

septiembre 12, 2023

Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression

septiembre 7, 2023

The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.

The Code Breaker

septiembre 6, 2023

Magnifica historia, biográfica y científica, del descubrimiento e implicaciones del método CRISPr que valió el premio Nobel a sus dos descubridores.

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

septiembre 1, 2023

The results of this post hoc analysis support the hypothesis that benralizumab reduces the risk for recurrent COPD exacerbations within the vulnerable 30-to-90–day period in the previously identified responder population.

Alvar Agustí presentations on COPD GOLD 2023 webinar

agosto 21, 2023

Mediante esta noticia ponemos a vuestra disposición los documentos de las presentaciones de Alvar Agustí durante la sesión del Webinar «JOINT WEBINAR ON COPD 2023 GUIDELINES»

Joint webinar on GOLD COPD GUIDELINES

agosto 9, 2023

Joint webinar on GOLD COPD GUIDELINES, Next Saturday, 12 August 2023 from 8:00 to 9:10 (CEST/UTC+2)

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee

agosto 2, 2023

GOLD Scientific Committee responses the five letters received in relation to the recent publication of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023.

NOVEDADES GOLD 2024 – 21 Noviembre 2023. 17-19h

The song of the cell: una exploración de la medicina y del nuevo humano

Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice

COPD and multimorbidity: recognising and addressing a syndemic occurrence

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression

The Code Breaker

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

Alvar Agustí presentations on COPD GOLD 2023 webinar

Joint webinar on GOLD COPD GUIDELINES

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2023 © Cátedra UB de Salud Respiratoria. All rights reserved.